Malaria RTS,S Vaccine from Canada
Recombinant circumsporozoite protein-based vaccine with AS01 adjuvant for Plasmodium falciparum. HTS 3002.49.0050 as other protozoal culture-derived prophylactic.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Declare adjuvant composition; multi-dose vial stability data
• Endemic import quotas may apply; CDC collaboration proof
• Reclass risk if adjuvant dominant to 3003